ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Tolerability of Mycophenolate Mofetil in Elderly Kidney Transplant Recipients: A Retrospective Cohort Study

S. Witek1, G. Malat2, D. Sawinski2, C. Sammons2, C. LaFratte1, A. Forte1, R. Samudralwar1, S. Lyle1, J. Rashid1, J. Trofe-Clark2

1Dept of Pharmacy, Hospital of the Univ of Pennsylvania, Philadelphia, PA, 2Penn Transplant Institute, Hospital of the Univ of Pennsylvania, Philadelphia, PA

Meeting: 2021 American Transplant Congress

Abstract number: 945

Keywords: Elderly patients, Infection, Kidney transplantation, Mycophenolate mofetil

Topic: Clinical Science » Kidney » Kidney Immunosuppression: Novel Regimens and Drug Minimization

Session Information

Session Name: Kidney Immunosuppression: Novel Regimens and Drug Minimization

Session Type: Poster Abstract

Session Date & Time: None. Available on demand.

Location: Virtual

*Purpose: Optimal immunosuppression in elderly kidney transplant recipients (KTRs) is not well-defined, with MMF being poorly tolerated at standard doses. This study aims to compare MMF dose reduction incidence and reason(s) in elderly vs. non-elderly KTRs in the first yr after transplant with a protocol dose of 1g/day.

*Methods: In this IRB-approved, single-center retrospective cohort study, KTRs receiving rabbit antithymocyte globulin (rATG) induction, MMF 1g/day, tacrolimus, and prednisone, with ≥ 6 mos f/u were stratified by age [≥ 60 (elderly) or < 60 yrs (non-elderly)]. Only 1st or 2nd KTRs alone were considered. Primary outcome was MMF dose reduction incidence in the first yr, reviewed at defined intervals. Secondary outcomes include the indication for dose reduction, 1-yr patient/graft survival, and graft function.

*Results: An interim analysis included 133 KTRs (elderly n=51, non-elderly n=82). Groups were similar in demographics except for more living donors and lower kidney donor profile index (KDPI) in the non-elderly group (Table 1). MMF dose reductions occurred in 32 elderly and 50 non-elderly KTRs during the first yr (61% vs 63%, p=0.86) for reasons mentioned in Table 2. Most dose reductions occurred within 2 mos (elderly 31% vs. non-elderly 32%) with nearly all occurring between mos 2-6 (84% and 82%). At 1 yr, 47% elderly and 49% non-elderly were on MMF 1g/day (p=0.86), 6% and 13% were on 500mg/day (p=0.25), and 45% and 35% were on 0mg/day (p=0.28). There were no differences in 1-yr patient/graft survival or graft function.

 border=

 border=

*Conclusions: In this interim analysis, there was no difference in MMF dose reduction incidence between elderly vs non-elderly KTRs using 1g/day with rATG induction. Most dose reductions occurred in the first 6 mos post-transplant. The elderly KTR group more commonly required MMF dose reductions secondary to GI side effects and viral infections, including BK and CMV, although not statistically significant. Continued data collection/analysis is necessary to further elucidate this trend.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Witek S, Malat G, Sawinski D, Sammons C, LaFratte C, Forte A, Samudralwar R, Lyle S, Rashid J, Trofe-Clark J. Tolerability of Mycophenolate Mofetil in Elderly Kidney Transplant Recipients: A Retrospective Cohort Study [abstract]. Am J Transplant. 2021; 21 (suppl 3). https://atcmeetingabstracts.com/abstract/tolerability-of-mycophenolate-mofetil-in-elderly-kidney-transplant-recipients-a-retrospective-cohort-study/. Accessed June 1, 2025.

« Back to 2021 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences